In addition to targeting PI3K/Akt in cancer, the signal transducer and activator of the transcription 3 (STAT3) pathway counterbalances PI3K/Akt/mTOR signalling via PTEN and promotes tumourigenic proliferation, invasion, migration, and angiogenesis in most cancers [262]. This evidence concerns the gene STAT3 and cancer.